Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

OncoGenex Loss Lower than Expected
Yahoo/Zacks
Tuesday, March 12, 2013 - 11:37am
tags:
OncoGenex, earnings
Don't Blame AbbVie for Humira's Success
Motley Fool
Tuesday, March 12, 2013 - 11:36am
tags:
AbbVie, Humira
Some Experts Defend Niacin For Heart Disease After Failed Study
Forbes
Tuesday, March 12, 2013 - 11:33am
tags:
niacin, Merck, Niaspan, AbbVie
Overseas Tax Savings for U.S. Drugmakers Under Threat
Bloomberg
Tuesday, March 12, 2013 - 11:28am
tags:
Pfizer, Merck, JNJ, Bristol-Myers Squibb, taxes
Puma Biotechnology Priced Like Takeover Target: Real M&A
Bloomberg
Tuesday, March 12, 2013 - 11:26am
tags:
Puma Biotechnology, M&A, AstraZeneca, Bristol-Myers Squibb, Takeda, Celgene, GSK
DOJ Investigating Sanofi Over Plavix Disclosure
Motley Fool
Tuesday, March 12, 2013 - 11:25am
tags:
Sanofi, DOJ, Plavix, Bristol-Myers Squibb
J&J Seeks EU Nod for Combo Drug
Yahoo/Zacks
Tuesday, March 12, 2013 - 11:24am
tags:
Europe, JNJ, diabetes, canagliflozin, metformin
Pfizer Gains Notable Win And A Loss In Recent Pipeline Updates
Seeking Alpha
Tuesday, March 12, 2013 - 11:23am
tags:
Pfizer, PF-00868544, Inspra
U.S. FDA says Zithromax can cause fatal irregular heart rhythm
Reuters
Tuesday, March 12, 2013 - 11:13am
tags:
FDA, Zithromax, abnormal heart rhythms, antiobiotics, Pfizer
Cubist Pharma buys out antibiotic partner Astellas for $25M-plus
Fierce Biotech
Monday, March 11, 2013 - 12:34pm
tags:
Cubist Pharma, Astellas, ceftolozane
Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
Yahoo
Monday, March 11, 2013 - 12:33pm
tags:
Aeterna Zentaris, Multiple Myeloma, perifosine
Vivus investor plots board takeover to rally Qsymia sales
Fierce Pharma
Monday, March 11, 2013 - 12:26pm
tags:
Vivus, Qsymia
3 Undiscovered Biotech Companies For The Healthcare Investor
Seeking Alpha
Monday, March 11, 2013 - 12:25pm
tags:
NeoStem, Antares, Galena Biopharma
PDL BioPharma forecasts greater 1Q royalties
Yahoo/AP
Monday, March 11, 2013 - 12:24pm
tags:
PDL Biopharma
After FDA Approval, A New And Bigger Catalyst Looms Closer For Immunogen
Seeking Alpha
Monday, March 11, 2013 - 11:09am
tags:
Immunogen, trastuzumab, breast cancer
Ziopharm initiates Phase 2 study of Ad-RTLS IL-12
Yahoo/Fly on the Wall
Monday, March 11, 2013 - 11:07am
tags:
Ziopharm, Ad-RTS IL-12, breast cancer
Gilead drug reduces chest pain episodes in diabetics -study
Reuters
Monday, March 11, 2013 - 11:06am
tags:
diabetes, Gilead, angina, Ranexa
Merck KGaA Boosts Stock With Job Cuts Amid Drug Drought
Bloomberg
Monday, March 11, 2013 - 11:04am
tags:
Merck KGaA
Yet Another Negative Trial For Amgen's Aranesp
Forbes
Monday, March 11, 2013 - 11:03am
tags:
Amgen, Aranesp, anemia
New anti-inflammatory causes stir at ACC
Pharma Times, UK
Monday, March 11, 2013 - 11:00am
tags:
anti-inflammatories, Genmab, Roche, inclacumab, angioplasty

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.